TED Talks · Level C1 Mixing - Part 3
Why is it so hard to cure cancer
Why is it so difficult to cure cancer? We've harnessed electricity, sequenced the human genome, and eradicated small pox.
Level: C1 · 63 sentences
Transcript
- Why is it so difficult to cure cancer?
- We've harnessed electricity, sequenced the human genome, and eradicated small pox.
- But after billions of dollars in research,
- we haven't found a solution for a disease that affects more than 14 million people and their families at any given time.
- Cancer arises as normal cells accumulate mutations.
- Most of the time, cells can detect mutations or DNA damage
- and either fix them or self destruct.
- However, some mutations allow cancerous cells to grow unchecked
- and invade nearby tissues, or even metastasize to distant organs.
- Cancers become almost incurable once they metastasize.
- And cancer is incredibly complex.
- It's not just one disease.
- There are more than 100 different types
- and we don't have a magic bullet that can cure all of them.
- For most cancers, treatments usually include a combination of surgery to remove tumors
- and radiation and chemotherapy to kill any cancerous cells left behind.
- Hormone therapies, immunotherapy,
- and targeted treatments tailored for a specific type of cancer are sometimes used, too.
- In many cases, these treatments are effective and the patient becomes cancer-free.
- But they're very far from 100% effective 100% of the time.
- So what would we have to do to find cures for all the different forms of cancer?
- We're beginning to understand a few of the problems scientists would have to solve.
- First of all, we need new, better ways of studying cancer.
- Most cancer treatments are developed using cell lines grown in labs from cultures of human tumors.
- These cultured cells have given us critical insights about cancer genetics and biology,
- but they lack much of the complexity of a tumor in an actual living organism.
- It's frequently the case that new drugs, which work on these lab-grown cells, will fail in clinical trials with real patients.
- One of the complexities of aggressive tumors
- is that they can have multiple populations of slightly different cancerous cells.
- Over time, distinct genetic mutations accumulate in cells in different parts of the tumor,
- giving rise to unique subclones.
- For example, aggressive brain tumors called glioblastomas
- can have as many as six different subclones in a single patient.
- This is called clonal heterogeneity,
- and it makes treatment difficult because a drug that works on one subclone may have no effect on another.
- Here's another challenge.
- A tumor is a dynamic interconnected ecosystem
- where cancer cells constantly communicate with each other and with healthy cells nearby.
- They can induce normal cells to form blood vessels that feed the tumor and remove waste products.
- They can also interact with the immune system to actually suppress its function,
- keeping it from recognizing or destroying the cancer.
- If we could learn how to shut down these lines of communication,
- we'd have a better shot at vanquishing a tumor permanently.
- Additionally, mounting evidence suggests we'll need to figure out how to eradicate cancer stem cells.
- These are rare but seem to have special properties that make them resistant to chemotherapy and radiation.
- In theory, even if the rest of the tumor shrinks beyond detection during treatment,
- a single residual cancer stem cell could seed the growth of a new tumor.
- Figuring out how to target these stubborn cells might help prevent cancers from coming back.
- Even if we solved those problems, we might face new ones.
- Cancer cells are masters of adaptation,
- adjusting their molecular and cellular characteristics to survive under stress.
- When they're bombarded by radiation or chemotherapy,
- some cancer cells can effectively switch on protective shields against whatever's attacking them
- by changing their gene expression.
- Malignant cancers are complex systems that constantly evolve and adapt.
- To defeat them, we need to find experimental systems that match their complexity,
- and monitoring and treatment options that can adjust as the cancer changes.
- But the good news is we're making progress.
- Even with all we don't know,
- the average mortality rate for most kinds of cancer has dropped significantly since the 1970s
- and is still falling.
- We're learning more every day,
- and each new piece of information gives us one more tool to add to our arsenal.